Calvert Investment Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-36,299
Closed -$1.03M 642
2015
Q2
$1.03M Buy
+36,299
New +$1.06M 0.05% 232
2014
Q3
Sell
-112,142
Closed -$3.53M 609
2014
Q2
$3.53M Buy
112,142
+3,616
+3% +$115K 0.24% 106
2014
Q1
$3.51M Buy
108,526
+6,442
+6% +$226K 0.25% 103
2013
Q4
$3.71M Buy
102,084
+3,725
+4% +$145K 0.27% 102
2013
Q3
$3.83M Buy
98,359
+8,992
+10% +$362K 0.48% 81
2013
Q2
$3.35M Buy
+89,367
New +$3.53M 0.46% 87

Other funds holding MR

Calvert Investment Management's MR Position: Q3 2015 in Review

Calvert Investment Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q3 2015, closing a stake of 36,299 shares — an estimated $1.03M sold.

Calvert Investment Management first reported a position in MR in Q2 2013 and held it in 6 quarters. The position peaked at $3.83M in Q3 2013. 105 funds tracked by Wall St. Rank hold MR as of Q3 2015.

  • Calvert Investment Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q3 2015 after selling out during the quarter.
  • Calvert Investment Management sold 36,299 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q3 2015, an estimated $1.03M.
  • Calvert Investment Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 6 quarters.
  • Calvert Investment Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $3.83M in Q3 2013.
  • 105 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q3 2015.

Based on Calvert Investment Management's 13F filing for Q3 2015, filed 16 Nov 2015.